Verrica Pharmaceuticals Inc. revenue for the last year amounted to 7.57 M USD, the most of which — 7.57 M USD — came from its highest performing source at the moment, Novel Topical Solution of Cantharidin, the year earlier bringing 5.12 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Verrica Pharmaceuticals Inc. 7.57 M USD, and the year before that — 5.12 M USD.